What is the patient's cardiac valve function and overall cardiac health, given the provided echocardiogram (echo) data, including aortic valve (AV) peak velocity of 1.7 meters per second (m/s), mitral valve (MV) peak velocity of 1.2 m/s, tricuspid valve (TV) regurgitation, and pulmonic valve (PV) peak gradient of 4 millimeters of mercury (mmHg)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The patient has a normal cardiac valve structure and function, and therefore, does not require immediate intervention or frequent follow-up echocardiograms, but rather follow-up every 3-5 years as recommended for patients with valvular heart disease and normal left ventricular function 1.

Echocardiogram Findings

The echocardiogram shows normal cardiac valve structure and function. All four heart valves (aortic, mitral, tricuspid, and pulmonic) have normal structure with no significant stenosis.

  • The aortic valve has a peak velocity of 1.7 m/s with a peak gradient of 11 mmHg and mean gradient of 5 mmHg, all within normal limits.
  • The mitral valve area is 3.6 cm², which is normal.
  • There is trivial regurgitation noted in the mitral and tricuspid valves, which is considered a normal variant.
  • The inferior vena cava (IVC) has normal caliber at 1.3 cm with appropriate respiratory variation, suggesting normal right atrial pressure estimated at 3 mmHg.
  • The aortic root and ascending aorta dimensions are normal at 3 cm and 2.9 cm respectively.
  • There are no pericardial or pleural effusions, no intracardiac shunts, and no pacemaker present.

Follow-up Recommendations

According to the 2020 ACC/AHA guideline for the management of patients with valvular heart disease, patients with asymptomatic valvular heart disease and normal left ventricular function should undergo follow-up echocardiograms every 3-5 years 1.

  • This recommendation applies to patients with mild to moderate valve disease, and more frequent follow-up may be necessary for patients with severe valve disease or those with significant changes in symptoms or clinical status.
  • The use of echocardiography is essential in assessing the severity of valvular heart disease and guiding management decisions, as outlined in the European Heart Journal guidelines on the management of valvular heart disease 1.

Overall Assessment

Overall, this represents a normal cardiac ultrasound study with no significant abnormalities requiring intervention or frequent follow-up.

  • The patient's valve disease is classified as stage B, with no significant stenosis or regurgitation, and normal left ventricular function.
  • The patient can be managed conservatively with regular follow-up echocardiograms to monitor for any changes in valve function or disease progression.

From the Research

Valve Structure and Function

  • The aortic valve structure is normal with a peak velocity of 1.7 m/s and an LVOT peak velocity of 1.1 m/s 2.
  • The mitral valve structure is normal with a peak velocity of 1.2 m/s and a mean gradient of 2 mmHg 2.
  • The tricuspid valve structure is normal with a respiratory variation of >50% and a TR gradient 2.
  • The pulmonic valve structure is normal with a peak velocity of 1.0 m/s and a peak gradient of 4 mmHg 2.

Valve Stenosis and Regurgitation

  • Aortic valve stenosis is none with a peak gradient of 11 mmHg and a mean gradient of 5 mmHg 2.
  • Mitral valve stenosis is none with a peak gradient of 6 mmHg and a mean gradient of 2 mmHg 2.
  • Tricuspid valve regurgitation is trivial with a TR velocity of 1.2 m/s 2.
  • Pulmonic valve regurgitation is none 2.

Other Cardiac Parameters

  • The aortic root diameter is 3 cm and the ascending aorta is 2.9 cm 2.
  • Pericardial effusion is absent and shunts are none 2.
  • Pleural effusion is absent and pacemaker is absent 2.

Risk Factors for Valvular Heart Disease

  • Traditional cardiovascular risk factors such as hypertension, high cholesterol levels, diabetes mellitus, and active smoking are associated with an increased risk of valvular heart disease 3.
  • Diabetes and hypertension are closely interlinked due to similar risk factors such as endothelial dysfunction, vascular inflammation, and arterial remodelling 4.
  • Echocardiographic tissue Doppler imaging can reveal reduced myocardial function in hypertension, diabetes, and ischaemic heart disease 5.

Echocardiographic Assessment of Aortic Valve Stenosis

  • Echocardiography is the key tool for the diagnosis and evaluation of aortic stenosis 6.
  • The European Association of Cardiovascular Imaging and the American Society of Echocardiography have published recommendations on the echocardiographic assessment of aortic valve stenosis 6.
  • The assessment of aortic valve stenosis should include the optimization of left ventricular outflow tract assessment, low flow, low gradient aortic stenosis with preserved ejection fraction, and a new classification of aortic stenosis by gradient, flow, and ejection fraction 6.

Related Questions

What is the diagnosis for a patient with a normal mitral valve structure, trivial mitral regurgitation, normal tricuspid valve structure with trivial tricuspid regurgitation, and a normal pulmonic valve structure?
What is the next best step in management for an elderly patient with diabetes and hypertension experiencing nocturnal numbness and burning in their right foot, relieved by dependency?
What are the diagnostic criteria for aortic stenosis (Aortic Valve Stenosis)?
What is the diagnosis for an aortic valve with normal structure, peak velocity of 1.7 meters per second (m/s), left ventricular outflow tract (LVOT) peak velocity of 1.1 m/s, no stenosis, peak gradient of 11 millimeters of mercury (mmHg), no regurgitation, mean gradient of 5 mmHg, area of 2.4 square centimeters (cm²), and diameter of 2.1 centimeters (cm)?
What should a 72-year-old female's Medicare wellness exam include?
What is the lowest form of estrogen available for contraception (birth control)?
Do I need to check laboratory tests for patients taking orlistat (Xenical)?
What is the pathophysiology of Parathyroid Hormone (PTH) action on bone, kidneys, and the Gastrointestinal (GI) system?
Is there a difference in weight gain between 10 micrograms (mcg) of estrogen and 20 micrograms (mcg) of estrogen for contraceptive purposes?
What is the maximum amount of acyclovir (antiviral medication) topical cream that can be applied in one day?
What is the radiation exposure equivalent of 3 millicuries (mCi) of Iodine-131 (I-131)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.